Tammenoms Bakker Juliet (CIK 0001431159)

Latest company ownership

Shares held
3,429,927
Last filed at
Apr 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
CBLL - Ceribell, Inc.
Role: Director
Shares held
2,140,600
Last filed at
Oct 16, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2024Q4 2025Q4
KALA - KALA BIO, Inc.
Role: 10% Owner
Shares held
2,055,946
Last filed at
Jul 27, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
TRML - Tourmaline Bio, Inc.
Role: 10% Owner
Shares held
406,338
Last filed at
May 11, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
319,126
Last filed at
Nov 9, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4
Shares held
129,032
Last filed at
Jul 20, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
121,153
Last filed at
Nov 30, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
45,620
Last filed at
Dec 12, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
28,186
Last filed at
Nov 19, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
RXST - RxSight, Inc.
Role: Director
Shares held
1,548
Last filed at
Jun 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
ETNB - 89bio, Inc.
Role: 10% Owner
Shares held
891
Last filed at
Nov 18, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 11, 2024 Oct 16, 2024 Ceribell, Inc. Director Buy 100.0 +243,852 10.90% ✗ $4M
May 17, 2024 May 21, 2024 RxSight, Inc. Director Buy 97.5 +5,000 15.93% ✗ $305.5K
Feb 12, 2024 Feb 15, 2024 RxSight, Inc. Director Buy 97.5 +8,000 34.21% ✗ $406.7K
Nov 28, 2023 Nov 30, 2023 RxSight, Inc. Director Sell 15.0 -937,403 -71.56% ✗ $14.7M
Nov 14, 2023 Nov 16, 2023 RxSight, Inc. Director Sell 15.0 -500,000 -49.28% ✗ $13.6M
Nov 7, 2023 Nov 9, 2023 Lexeo Therapeutics, Inc. 10% Owner Buy 100.0 +454,545 21.52% ✗ $5M
Sep 7, 2023 Sep 11, 2023 RxSight, Inc. Director Sell 20.0 -32,950 -2.21% ✗ $993K
Aug 24, 2023 Aug 28, 2023 RxSight, Inc. Director Sell 20.0 -282,122 -36.10% ✗ $474.1K
Aug 17, 2023 Aug 18, 2023 RxSight, Inc. Director Sell 20.0 -33,135 -1.83% ✗ $981.6K
Feb 10, 2023 Feb 13, 2023 RxSight, Inc. Director Buy 100.0 +480,000 90.79% ✗ $6M
Feb 6, 2023 Feb 8, 2023 Vera Therapeutics, Inc. 10% Owner Buy 100.0 +1,714,285 100.00% ✗ $12M
Feb 10, 2022 Apr 5, 2022 Vera Therapeutics, Inc. 10% Owner Buy 100.0 +333,333 10.76% ✗ $5M
Aug 3, 2021 Aug 5, 2021 RxSight, Inc. Director Buy 100.0 +637,500 34.10% ✗ $10.2M
Jul 19, 2021 Jul 20, 2021 RAPID MICRO BIOSYSTEMS, INC. 10% Owner Buy 100.0 +150,000 100.00% ✗ $3M
May 18, 2021 May 18, 2021 Vera Therapeutics, Inc. 10% Owner Buy 100.0 +909,090 41.56% ✗ $10M
May 11, 2021 May 11, 2021 Tourmaline Bio, Inc. 10% Owner Buy 95.0 +235,000 7.87% ✗ $4M
Jul 10, 2020 Jul 14, 2020 89bio, Inc. 10% Owner Buy 92.5 +109,090 4.38% ✗ $3M
Nov 11, 2019 Nov 13, 2019 89bio, Inc. 10% Owner Buy 100.0 +575,000 100.00% ✗ $9.2M
Dec 8, 2017 Dec 12, 2017 COLLEGIUM PHARMACEUTICAL, INC 10% Owner Sell 15.0 -1,000,000 -30.10% ✗ $17.3M
Jul 25, 2017 Jul 27, 2017 KALA BIO, Inc. 10% Owner Buy 100.0 +215,000 10.46% ✗ $3.2M
Nov 22, 2016 Nov 25, 2016 CORCEPT THERAPEUTICS INC 10% Owner Sell 37.5 -36,941 -0.26% ✗ $345.2K
Nov 17, 2016 Nov 21, 2016 CORCEPT THERAPEUTICS INC 10% Owner Sell 16.3 -544,100 -3.74% ✗ $5.2M
Nov 15, 2016 Nov 17, 2016 CORCEPT THERAPEUTICS INC 10% Owner Sell 17.5 -174,847 -1.19% ✗ $1.7M
May 12, 2015 May 14, 2015 COLLEGIUM PHARMACEUTICAL, INC 10% Owner Buy 95.0 +200,000 6.41% ✗ $2.4M
Mar 20, 2015 Mar 24, 2015 CORCEPT THERAPEUTICS INC 10% Owner Sell 16.3 -1,089,745 -2.67% ✗ $6.3M
Nov 17, 2014 Nov 19, 2014 Esperion Therapeutics, Inc. 10% Owner Sell 2.5 -487,130 -25.35% ✓ $16M
Oct 9, 2014 Oct 14, 2014 Esperion Therapeutics, Inc. 10% Owner Sell 57.5 -943 -0.05% ✓ $28.3K
Oct 7, 2014 Oct 9, 2014 Esperion Therapeutics, Inc. 10% Owner Sell 45.0 -11,927 -0.62% ✓ $358.3K
May 1, 2014 May 5, 2014 CORCEPT THERAPEUTICS INC 10% Owner Sell 42.5 -250,000 -0.97% ✓ $1M
Apr 1, 2014 Apr 3, 2014 CORCEPT THERAPEUTICS INC 10% Owner Sell 40.0 -250,000 -1.90% ✓ $1.1M
Mar 5, 2014 Mar 7, 2014 CORCEPT THERAPEUTICS INC 10% Owner Sell 42.5 -250,000 -0.63% ✓ $1M
Jul 1, 2013 Jul 1, 2013 Esperion Therapeutics, Inc. 10% Owner Buy 100.0 +216,676 12.61% ✗ $3M